{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:35:31Z","timestamp":1792712131843,"version":"4.5.0"},"reference-count":37,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2501,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p> <jats:bold>Background:<\/jats:bold>\u2002The diagnosis of IgE\u2010mediated immediate reactions to penicillins can be supported by <jats:italic>in vivo<\/jats:italic> or <jats:italic>in vitro<\/jats:italic> tests using classical benzylpenicillin determinants. The wide variety of \u03b2\u2010lactams and the description of new specificities requires a re\u2010evaluation of the different tests available. The objective was to evaluate the diagnostic capacity of Pharmacia CAP System<jats:sup>\u2122<\/jats:sup> RAST FEIA amoxicilloyl c6 (AXO) and benzylpenicilloyl c1 (BPO) in patients with a documented IgE\u2010mediated penicillin allergy.<\/jats:p><jats:p> <jats:bold>Methods:<\/jats:bold>\u2002We studied 129 patients in five groups. Groups 1, 2, and 3 had developed an immediate reaction after penicillin treatment. Group 1 (<jats:italic>n<\/jats:italic>=19) were skin test positive to amoxicillin (AX) and\/or BPO and\/or minor determinant mixture (MDM); group 2 (<jats:italic>n<\/jats:italic>=29) were skin test positive to AX but negative to BPO and MDM; and group 3 (<jats:italic>n<\/jats:italic>=26) were skin test negative to all determinants, the diagnosis being confirmed by a previous repetitive history or controlled administration. Two control groups, one with nonimmediate reactions \u2013 group 4 (<jats:italic>n<\/jats:italic>=25) \u2013 and one with good tolerance to penicillin \u2013 group 5 (<jats:italic>n<\/jats:italic>=30) \u2013 were included. All samples were analyzed <jats:italic>in vitro<\/jats:italic> for AXO and BPO, and the results compared to the <jats:italic>in vivo<\/jats:italic> diagnosis.<\/jats:p><jats:p> <jats:bold>Results:<\/jats:bold>\u2002AX was the drug most often involved. In group 1, 53% were <jats:italic>in vitro<\/jats:italic> positive for AXO and 68% for BPO, but 74% had at least one positive test result. In group 2, only 10% had a positive <jats:italic>in vitro<\/jats:italic> test to BPO compared to 41% to AXO. In group 3, 42% had positive BPO and\/or AXO <jats:italic>in vitro<\/jats:italic> tests. In the control groups 4 and 5, the negative <jats:italic>in vitro<\/jats:italic> results for AXO were 96% and 100%, and for BPO 100% and 97%, respectively. A positive correlation between specific IgE levels and the time interval from the reaction to the evaluation was found only for group 3.<\/jats:p><jats:p> <jats:bold>Conclusions<\/jats:bold>:\u2002This <jats:italic>in vitro<\/jats:italic> assay is beneficial for evaluating subjects allergic to \u03b2\u2010lactams. It is necessary to test for specific IgE to AXO in addition to BPO in patients with immediate allergic reactions after AX. The combination of <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> tests for estimating IgE antibodies to penicillins is important because of the existence of patients with a positive history but negative skin test.<\/jats:p>","DOI":"10.1034\/j.1398-9995.2001.00995.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T01:47:17Z","timestamp":1047347237000},"page":"862-870","source":"Crossref","is-referenced-by-count":151,"title":["Clinical evaluation of Pharmacia CAP System<sup>\u2122<\/sup> RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy"],"prefix":"10.1111","volume":"56","author":[{"given":"M.","family":"Blanca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","volume-title":"Allergic drug reactions","author":"Amos HE","year":"1976"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-69088-4_16"},{"key":"e_1_2_6_4_2","first-page":"73","volume-title":"The anti\u2010gens","author":"Dewdeney JM","year":"1977"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/206362a0"},{"key":"e_1_2_6_6_2","first-page":"1065","volume-title":"The pharmacological basis of therapeutics","author":"Mandell GL","year":"1990"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1995.tb05048.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.1999.00175.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1988.tb02904.x"},{"key":"e_1_2_6_10_2","first-page":"85","article-title":"Allergic reactions in man","volume":"34","author":"Parker CW","year":"1982","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1976.tb00715.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1990.tb03139.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb02275.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1997.tb02550.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1971.tb03016.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0019-2791(72)90112-7"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90279-4"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00928.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000235177"},{"key":"e_1_2_6_20_2","first-page":"515","article-title":"Allergy to cefazolin: study of in vivo cross reactivity with other betalactams","volume":"68","author":"Igea JM","year":"1992","journal-title":"Ann Allergy"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70368-9"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70100-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb00809.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1996.tb04634.x"},{"key":"e_1_2_6_25_2","first-page":"297","volume-title":"Allergy: principles and practice","author":"Norman PS","year":"1983"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90188-L"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb04157.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug\u2010induced cutaneous reactions: a report from Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby M","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_6_29_2","first-page":"187","article-title":"Cephalosporin allergy: characterization of unique and cross\u2010reacting cephalosporin antigens","volume":"10","author":"Romano A","year":"1997","journal-title":"Int J Immunopathol Pharmacol"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(00)91443-X"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1981.tb02178.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1979.tb02516.x"},{"key":"e_1_2_6_33_2","first-page":"166","article-title":"The nature of the carrier in the RAST assay influences the capacity for detecting IgE antibodies to penicillins","volume":"17","author":"Blanca M","year":"1994","journal-title":"J Clin Immunoassay"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/bc980023r"},{"key":"e_1_2_6_35_2","first-page":"554","volume-title":"Allergy; principles and practice","author":"Homburger HA","year":"1993"},{"key":"e_1_2_6_36_2","first-page":"881","volume-title":"Manual of clinical laboratory immunology","author":"Hamilton RC","year":"1997"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70439-2"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1996.tb00100.x"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1398-9995.2001.00995.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1398-9995.2001.00995.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:32:07Z","timestamp":1695904327000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1398-9995.2001.00995.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1034\/j.1398-9995.2001.00995.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1398-9995.2001.00995.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}